| abstract |
The invention discloses a sulfated polysaccharide inhalation preparation and its application in preventing and treating new coronavirus-related diseases. The preparation includes sulfated polysaccharide and pharmaceutically acceptable excipients, and the sulfated polysaccharide includes non-anticoagulant heparin, pentosan sulfate One or more of sugar, PI-88, chondroitin sulfate, chondroitin persulfate, dermatan sulfate, sea cucumber glycosaminoglycan and sea cucumber fucoidan. The sulfated polysaccharide inhalation preparation of the invention has good stability and can be stored for a long time without deterioration and discoloration. At the same time, using the administration method of sulfated polysaccharide inhalation preparations, the sulfated polysaccharide drugs can be directly delivered to the lungs of new crown patients, with precise positioning and rapid onset of effects. According to the advantages of inhalation preparation administration, the present invention can prevent and treat diseases such as antiviral, anti-inflammatory and anticoagulant thrombosis for patients with novel coronavirus by introducing sulfated polysaccharide drugs. |